Aurgalys

Philippe Berthon, PhD

Chief Executive Officer – Paris France
ph.berthon@aurgalys.com

Philippe Berthon is Founder and General Partner of Aurgalys, also board member of France Biotech & Essonne Economy Agency. Previously, Dr Berthon was Chief Executive Officer of Vaxon-Biotech (2004-2008), a company developing cancer immunotherapeutic products, including Vx-001 due to enter phase III in 2009.  He founded UroGene in 1998, was successively CEO and President & CSO and was involved in the raising of 25M€. Prior to these appointments, Dr Berthon was co-founder and CEO of CeRePP at Hospital Saint Louis, Paris, from 1995-1999; senior post-doctoral fellow at the Cancer Research Unit, University of York, UK, for 3 years; and research fellow at Paris VI University for 5 years. Dr Berthon co-authored more than 50 peer-reviewed international publications,  received his PhD in Reproduction Physiology at Paris VI University, and graduated from Challenge+ Business and Administration program, HEC School of Management, Jouy en Josas, France.

Manuel Vega, PhD

Aurgalys Partner - Paris France
m.vega@aurgalys.com

Dr Vega is partner of Aurgalys based at the Evry-Paris office. Manuel Vega joined Aurgalys in 2010 from L&M Crecer, a business & technology consulting firm between Argentina and France. Previously, Dr Vega was founder and Chief Executive Officer of Nautilus Biotech (US and France)  from 1999 to 2007, for which he closed €40M+ corporate deals and  raised  about  €30M€, mostly in private equity financing. For his previous appointments, Dr Vega was Director Development & Production at Genethon, France (1997-1999) , Managing Director of Microgen, Argentina (1993-1995), and from 1988 to 1993 held several senior academic positions in major institutes (INSERM, EMBO), in France and Germany . Dr Vega co-authored 25 peer-reviewed international publications, received his PhD in Biology at Universidad Nacional del Sur, Argentina.

Serge Goldner

Business Affiliate, CLS Managing Partner – Tel Aviv Israel
serge.g@cukierman.co.il
Serge Godner is managing partner of Cukierman & Co Life Sciences.  Mr  Goldner joined Cukierman & Co. in 2005 as an investment banker within the corporate finance division. In 2006 he founded Cukierman & Co. Life Sciences, the Life Sciences corporate finance arm of the group. He brings 12 years of business development and 2 ventures management experience in the services and telecom businesses. Serge served in the Israeli Defense Forces as a Company Commander of the artillery unit and was instructor in the Commander course. Serge Goldner holds a BA in Political Science and International Relations from the Hebrew University of Jerusalem, Israel.

Laurent Choppe, DVM, MBA

Business Affiliate, CLS Managing Partner – Lausanne Switzerland
laurent.c@cukierman.eu
Dr. Laurent Choppe is managing partner of Cukierman & Co Life Sciences. Dr Choppe brings to CLS an extensive international life science experience in managing multi-functional teams and setting up new businesses in pharmaceuticals, biotechnology, nutraceuticals, animal health and direct-to-consumer markets. After a veterinary practice and a new venture management experience, he joined Schering-Plough in 1994 by leading the marketing of major drugs in dermatology, allergy, respiratory and animal health in France, became General Manager and established the first subsidiary in Israel and moved up to Vice President, Virology, Oncology and Cardiology in Canada. From 2004 to 2008, he served as the General Manager of the international headquarters of BELLUS Health (NASDAQ & TSE), a global pharmaceutical and nutraceutical company addressing unmet needs in Alzheimer’s disease, AA amyloidosis, diabetes, memory and cognition. Dr. Choppe is a Doctor of Veterinary Medicine of the University Paris XII, laureate of the Ecole Nationale Veteinaire d’Alfort and earned a MBA from INSEAD in Fontainebleau, France.

Lila Drittanti, PhD

Aurgalys Partner – Buenos Aires Argentina
l.drittanti@aurgalys.com
Dr Vega is partner of Aurgalys based in Buenos Aires, Argentina. Dr Drittanti joined Aurgalys as partner in 2010 where she brings 25 years of management of research and clinical development, including more than 15 years in the pharma-biotech industry. Recently, she has been involved in advising South American based biotech companies and institutions as Chief Executive Officer of L&M Crecer Argentinean office.  Previously Dr Drittanti was VP R&D of Nautilus Biotech (2000-2007), held several senior academic positions in Argentina, Germany and France, co-authored about 20 international peer-reviewed publications, was inventor in 13 patents, received her PhD in Biology from UNS (1988), Argentina.

Miguel Esquivel

Director, Business Development
m.esquivel@aurgalys.com

Miguel Esquivel is Aurgalys Director, Business Development. Mr Esquivel brings 10 years of sales and marketing experience in various industries, including finance and real estate. He also managed subsidiaries of UK-based companies in the data base market. Mr Esquivel owns a Master in Strategy and International Trade from Evry University, France.